CDC Considers Major COVID Vaccine Shakeup | JQJO

The CDC is considering a major shift in its COVID-19 vaccine recommendations, moving from yearly boosters for all adults and children over six months to a risk-based approach focusing on vulnerable populations. This potential change, discussed by a CDC panel, could significantly impact pharmaceutical companies' profits. The decision follows a historically delayed meeting amid concerns about potential influence from the new health chief, Robert F. Kennedy Jr., a vaccine skeptic. A final vote is expected in June. Currently, low public enthusiasm and the US's outlier approach to widespread booster recommendations contribute to the debate.